Advanced Search
Contact | Corporate | Help
  • Home
  • Software Solutions
    • Login Now
    • Supplier Management(SRM) >>
      • Overview
      • CMO/CRO Projects
      • Construction Projects
      • Equipment Purchases
      • HR Services
      • Sales and Marketing
      • Security
      • Login Now
    • Client Portal >>
      • Overview
      • Security
      • Login Now
    • Software-as-a-Service
    • RFP Calculator
    • Product Tour
    • FAQs
  • Resources
    • Clinical Trials
    • Company Directories >>
      • Biotech & Pharma
      • CMOs & CROs
      • Engineering & Architecture
      • HR & Recruiters
      • Law Firms
      • Real Estate
    • Events
    • Jobs
    • News >>
      • Current News
      • May 23, 2012
      • May 22, 2012
      • May 21, 2012
      • May 17, 2012
      • May 16, 2012
      • May 15, 2012
      • May 14, 2012
      • May 11, 2012
      • May 10, 2012
      • May 09, 2012
      • May 08, 2012
      • May 07, 2012
      • May 06, 2012
      • Apr 25, 2012
      • Apr 24, 2012
    • Industry Organizations
    • Regulatory Resources >>
      • Consultants
      • FDA Documents
      • ICH Documents
      • Worldwide Agencies
    • Useful Websites
  • Corporate
    • About Us
    • Careers
    • Corporate News
    • Contact
    • Partners
    • SourceSolution IQPC Workshop

  • Company Directories >>
    • CMOs/CROs
    • Biotech/Pharma
    • Professional Services
    • Regulatory Consultants
  • Events
  • News >>
    • Current News
    • Daily News Email Sign-up
  • Industry Organizations
  • Jobs
  • Regulatory Resources >>
    • FDA Documents
    • ICH Documents
    • Regulatory Agencies
    • Documents
    • Useful Websites
  • Clinical Trials

Ancora Bookmark and Share

  • Overview
  • LinkedIn®
  • Visit
  • Jobs
  • News
  • Pipleline
  • Management
ArticleDateSource
Nuovi dati presentati al 64o incontro annuale dell'American Academy of Neurology (AAN) evidenziano l'impegno di Biogen Idec nello sviluppo di terapie promettenti per fabbisogni ancora insoddisfatti nelle malattie neurodegenerativeApril 22, 2012FDA News - Business Wire
Riassunto: New Health Capital Partners annuncia il perfezionamento di un fondo d’investimento con un investimento ancora da parte di ORIX USA Asset ManagementSeptember 21, 2011Pharma News - Business Wire
Ancora Receives Federal Grant for Malaria and Staphylococcal Vaccine DevelopmentDecember 06, 2010Pharma News - Business Wire
Dr. George Siber Joins Ancora Pharmaceuticals Scientific Advisory BoardOctober 28, 2010Pharma News - Business Wire
Ancora Pharmaceuticals Welcomes Dr. Florian Schödel as Scientific AdvisorOctober 21, 2010FDA News - Business Wire
Riassunto: WIN Symposium: sono ancora aperte le registrazioni per l'evento esclusivo dedicato alla medicina personalizzata per il trattamento dei tumoriJune 29, 2010Pharma News - Business Wire
<b>Barry Buckland</b> Joins Ancora Pharmaceuticals Board February 25, 2010BioSpace - Breaking News
Barry Buckland Joins Ancora Pharmaceuticals BoardFebruary 25, 2010FDA News - Business Wire



View all the latest news

SourceSolution © 2008-2012